4.8 Article

Memory Inflation Drives Tissue-Resident Memory CD8+ T Cell Maintenance in the Lung After Intranasal Vaccination With Murine Cytomegalovirus

Journal

FRONTIERS IN IMMUNOLOGY
Volume 9, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2018.01861

Keywords

CD8(+) T cells; cytomegalovirus; memory inflation; respiratory syncytial virus; tissue-resident memory; vaccine

Categories

Funding

  1. National Institutes of Health
  2. Wellcome Trust [100326/Z/12/Z] Funding Source: researchfish

Ask authors/readers for more resources

Tissue-resident memory T (T-RM) cells provide first-line defense against invading pathogens encountered at barrier sites. In the lungs, T-RM cells protect against respiratory infections, but wane more quickly than T-RM cells in other tissues. This lack of a sustained T-RM population in the lung parenchyma explains, at least in part, why infections with some pathogens, such as influenza virus and respiratory syncytial virus (RSV), recur throughout life. Intranasal (IN) vaccination with a murine cytomegalovirus (MCMV) vector expressing the M protein of RSV (MCMV-M) has been shown to elicit robust populations of CD8(+) T-RM cells that accumulate over time and mediate early viral clearance. To extend this finding, we compared the inflationary CD8(+) T cell population elicited by MCMV-M vaccination with a conventional CD8(+) T cell population elicited by an MCMV vector expressing the M2 protein of RSV (MCMV-M2). Vaccination with MCMV-M2 induced a population of M2-specific CD8(+) T-RM cells that waned rapidly, akin to the M2-specific CD8(+) T-RM cell population elicited by infection with RSV. In contrast to the natural immunodominance profile, however, coadministration of MCMV-M and MCMV-M2 did not suppress the M-specific CD8(+) T cell response, suggesting that progressive expansion was driven by continuous antigen presentation, irrespective of the competitive or regulatory effects of M2-specific CD8(+) T cells. Moreover, effective viral clearance mediated by M-specific CD8(+) T-RM cells was not affected by the coinduction of M2-specific CD8(+) T cells. These data show that memory inflation is required for the maintenance of CD8(+) T-RM cells in the lungs after IN vaccination with MCMV.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Oncology

What's next in cancer immunotherapy?-The promise and challenges of neoantigen vaccination

Alec J. Redwood, Ian M. Dick, Jenette Creaney, Bruce W. S. Robinson

Summary: The process of tumorigenesis results in genetic changes in tumor cells that have potential to serve as tumor-specific immune targets when expressed. Neoantigen vaccines, harnessing this immunogenicity, have shown efficacy in preclinical models and are now in clinical trials. The challenges in the personalized neoantigen vaccine field include identifying targetable antigens and addressing preexisting immunosuppression, particularly T-cell exhaustion, for the development of effective cancer vaccines.

ONCOIMMUNOLOGY (2022)

Article Medicine, Research & Experimental

A congenital CMV infection model for follow-up studies of neurodevelopmental disorders, neuroimaging abnormalities, and treatment

Yue-Peng Zhou, Meng-Ji Mei, Xian-Zhang Wang, Sheng-Nan Huang, Lin Chen, Ming Zhang, Xin-Yan Li, Hai-Bin Qin, Xiao Dong, Shuang Cheng, Le Wen, Bo Yang, Xue-Fang An, Ao-Di He, Bing Zhang, Wen-Bo Zeng, Xiao-Jun Li, Youming Lu, Hong-Chuang Li, Haidong Li, Wei-Guo Zou, Alec J. Redwood, Simon Rayner, Han Cheng, Michael A. McVoy, Qiyi Tang, William J. Britt, Xin Zhou, Xuan Jiang, Min-Hua Luo

Summary: The study developed a congenital murine CMV infection mouse model that mimicked clinical manifestations of cCMV infection in infants, allowing for investigation of mechanisms of infection-induced brain damage and the effectiveness of antiviral treatment in mitigating neurological functions and brain damage.

JCI INSIGHT (2022)

Article Gastroenterology & Hepatology

Mechanisms of CD8+T-cell failure in chronic hepatitis E virus infection

Janine Kemming, Swantje Gundlach, Marcus Panning, Daniela Huzly, Jiabin Huang, Marc Luetgehetmann, Sven Pischke, Julian Schulze Zur Wiesch, Florian Emmerich, Sian Llewellyn-Lacey, David A. Price, Yakup Tanriver, Klaus Warnatz, Tobias Boettler, Robert Thimme, Maike Hofmann, Nicole Fischer, Christoph Neumann-Haefelin

Summary: Chronic HEV infection is associated with exhaustion of HEV-specific CD8+ T cells, indicating that T-cell failure is driven by persistent antigen recognition in severely immunosuppressed hosts. Functional reinvigoration of virus-specific T cells is at least partially possible when the antigen is cleared. Viral escape in a minority of patients also contributes to the failure of HEV-specific CD8+ T cells.

JOURNAL OF HEPATOLOGY (2022)

Article Cell Biology

Epitope length variants balance protective immune responses and viral escape in HIV-1 infection

Phillip Pymm, Stefan Tenzer, Edmund Wee, Mirjana Weimershaus, Anne Burgevin, Simon Kollnberger, Jan Gerstoft, Tracy M. Josephs, Kristin Ladell, James E. McLaren, Victor Appay, David A. Price, Lars Fugger, John I. Bell, Hansjoerg Schild, Peter van Endert, Maria Harkiolaki, Astrid K. N. Iversen

Summary: This study discovers that the cytotoxic T lymphocyte (CTL) and natural killer (NK) cell responses to a specific epitope in the human immunodeficiency virus are associated with enhanced immune control. The length and mutations of the epitope influence the CTL and NK cell responses, leading to viral escape.

CELL REPORTS (2022)

Article Cell Biology

Elicitation of pneumovirus-specific B cell responses by a prefusion-stabilized respiratory syncytial virus F subunit vaccine

Emily Phung, Lauren A. Chang, Maryam Mukhamedova, Lijuan Yang, Deepika Nair, Scott A. Rush, Kaitlyn M. Morabito, Jason S. McLellan, Ursula J. Buchholz, John R. Mascola, Michelle C. Crank, Grace Chen, Barney S. Graham, Tracy J. Ruckwardt

Summary: RSV pre-F vaccination results in expansion and activation of RSV and HMPV F-specific B cells that contribute to long-term pneumovirus immunity.

SCIENCE TRANSLATIONAL MEDICINE (2022)

Article Hematology

Cellular and humoral response to the fourth BNT162b2 mRNA COVID-19 vaccine dose in patients with CLL

Ohad Benjamini, Rotem Gershon, Erez Bar-Haim, Yaniv Lustig, Hila Cohen, Ram Doolman, Meirav Kedmi, Elena Ribakovsky, Abraham Kneller, Tammy Hod, Noam Erez, Itzhak Levy, Galia Rahav, Abraham Avigdor

Summary: This study assessed the immune response in patients with CLL after receiving the fourth dose of the BNT162b2 mRNA COVID-19 vaccine. The results showed that the serologic response in CLL patients improved to a lesser extent than in healthy controls, but there was an improvement in T-cell response. During the three months after the fourth vaccine, 21% of patients developed COVID-19 infection, but all recovered without complications.

EUROPEAN JOURNAL OF HAEMATOLOGY (2023)

Article Cell Biology

A prefusion-stabilized RSV F subunit vaccine elicits B cell responses with greater breadth and potency than a postfusion F vaccine

Lauren A. Chang, Emily Phung, Michelle C. Crank, Kaitlyn M. Morabito, Tonya Villafana, Filip Dubovsky, Judith Falloon, Mark T. Esser, Bob C. Lin, Grace L. Chen, Barney S. Graham, Tracy J. Ruckwardt

Summary: This study evaluated the effect of the respiratory syncytial virus (RSV) fusion protein (F) conformation on B cell responses in a comparison of two vaccine clinical trials. The results showed that DS-Cav1 vaccine elicited antibodies that more potently neutralized both RSV A and B, and activated B cells preferentially binding the pre-fusion probe. This highlights the importance of using pre-F as an immunogen for eliciting highly potent neutralizing antibodies and memory B cells.

SCIENCE TRANSLATIONAL MEDICINE (2022)

Article Immunology

Ageing Curtails the Diversity and Functionality of Nascent CD8+ T Cell Responses against SARS-CoV-2

Davide Proietto, Beatrice Dallan, Eleonora Gallerani, Valentina Albanese, Sian Llewellyn-Lacey, David A. Price, Victor Appay, Salvatore Pacifico, Antonella Caputo, Francesco Nicoli, Riccardo Gavioli

Summary: Age-related changes in the immune system affect the ability of elderly individuals to generate effective CD8(+) T cell responses against SARS-CoV-2. Elderly individuals show a deficit in priming naive precursors into effector CD8(+) T cells, resulting in reduced diversity and expression frequency of IFN-gamma in CD8(+) T cell responses. These findings have implications for developing strategies to protect the elderly against COVID-19.

VACCINES (2023)

Article Biology

The superantigens SpeC and TSST-1 specifically activate TRBV12-3/12-4+ memory T cells

Freya R. R. Shepherd, Kate Davies, Kelly L. L. Miners, Sian Llewellyn-Lacey, Simon Kollnberger, James E. E. Redman, Melissa M. M. Grant, Kristin Ladell, David A. A. Price, James E. E. McLaren

Summary: Severe bacterial or viral infections can lead to an overactive immune response known as a cytokine storm. Superantigens are potent toxins that activate T cells non-specifically, leading to T cell dysfunction and immune evasion. This study found that TRBV12-3/12-4(+) T cells are highly responsive to streptococcal pyrogenic exotoxin C (SpeC) and toxic shock syndrome toxin-1 (TSST-1).

COMMUNICATIONS BIOLOGY (2023)

Article Immunology

CD4+T cell-mediated recognition of a conserved cholesterol-dependent cytolysin epitope generates broad antibacterial immunity

Lisa Ciacchi, Martijn D. B. van de Garde, Kristin Ladell, Carine Farenc, Martien C. M. Poelen, Kelly L. Miners, Carmen Llerena, Hugh H. Reid, Jan Petersen, David A. Price, Jamie Rossjohn, Cecile A. C. M. van Els

Summary: A new research found that the immune responses against Streptococcus pneumoniae are mediated by CD4+ T cells. The study identified an immunodominant CD4+ T cell epitope from pneumolysin, which can be presented by different HLA allotypes and recognized by diverse TCRs. The immunogenicity of this epitope is determined by core residues in a conserved undecapeptide region, enabling cross-recognition of heterologous bacterial pathogens. These findings provide insights into the immune response against bacterial infections and can inform strategies to combat life-threatening infectious diseases.

IMMUNITY (2023)

Review Immunology

Human circulating and tissue-resident memory CD8+ T cells

Marcus Buggert, David A. Price, Laura K. Mackay, Michael R. Betts

Summary: Our current understanding of human memory CD8(+) T cells mainly comes from studies of the intravascular space, but new data challenges some established ideas and suggests the need for conceptual revision. This review provides a brief history of the field and summarizes the biology of circulating and tissue-resident memory CD8(+) T cells, which play a crucial role in immune surveillance. The authors also discuss how future human studies can improve our understanding of CD8(+) T cells and inform the development of better immunotherapies and vaccines.

NATURE IMMUNOLOGY (2023)

Article Multidisciplinary Sciences

EV-D68 virus-like particle vaccines elicit cross-clade neutralizing antibodies that inhibit infection and block dissemination

Peter W. Krug, Lingshu Wang, Wei Shi, Wing-Pui Kong, Daniel L. Moss, Eun Sung Yang, Brian E. Fisher, Kaitlyn M. Morabito, John R. Mascola, Masaru Kanekiyo, Barney S. Graham, Tracy J. Ruckwardt

Summary: The study demonstrates that virus-like particle (VLP) vaccines can generate a protective neutralizing antibody against homologous and heterologous EV-D68 subclades. The B1 subclade VLP vaccine showed comparable neutralizing activity as an inactivated viral particle vaccine, while the B3 VLP vaccine exhibited improved cross-neutralization against heterologous viruses. The use of a carbomer-based adjuvant, Adjuplex, achieved a balanced CD4+ T helper response and generated robust neutralizing antibodies against both homologous and heterologous subclade viruses.

SCIENCE ADVANCES (2023)

Article Multidisciplinary Sciences

A single-dose F1-based mRNA-LNP vaccine provides protection against the lethal plague bacterium

Edo Kon, Yinon Levy, Uri Elia, Hila Cohen, Inbal Hazan-Halevy, Moshe Aftalion, Assaf Ezra, Erez Bar-Haim, Gonna Somu Naidu, Yael Diesendruck, Shahar Rotem, Nitay Ad-El, Meir Goldsmith, Emanuelle Mamroud, Dan Peer, Ofer Cohen

Summary: This study developed an effective mRNA-LNP vaccine against a lethal bacterial pathogen by optimizing mRNA payload and antigen design. The vaccine elicited immune responses and provided rapid, full protection against the bacterial infection in mice after a single dose. These findings open avenues for urgently needed effective antibacterial vaccines.

SCIENCE ADVANCES (2023)

Correction Immunology

Human circulating and tissue-resident memory CD8(+) T cells (vol 24, pg 1076, 2023)

Marcus Buggert, David A. Price, Laura K. Mackay, Michael R. Betts

NATURE IMMUNOLOGY (2023)

Article Biochemistry & Molecular Biology

Identification of T-Cell Epitopes Using a Combined In-Silico and Experimental Approach in a Mouse Model for SARS-CoV-2

Noam Erez, Hagit Achdout, Yfat Yahalom-Ronen, Shimrit Adutler-Lieber, Liat Bar-On, Erez Bar-Haim, Boaz Politi, Einat B. Vitner, Hadas Tamir, Sharon Melamed, Nir Paran, Tomer Israely

Summary: Following viral infection, T-cells play a crucial role in the immune response. To evaluate the cellular response after vaccination or infection, a reliable activity assay is needed. This study describes two methods, peptide library and computational scanning combined with a cellular activity assay, to identify T cell epitopes of the SARS-CoV-2 surface glycoprotein. Four CD8 T cell epitopes were identified, including a novel epitope. This research could aid in antigen design for vaccination and establish cellular activity assays for emerging pathogens.

CURRENT ISSUES IN MOLECULAR BIOLOGY (2023)

No Data Available